PHF6 and neoplasm: Despite PHF6 mutations leading to inactivation of the protein, an analysis of PHF6 expression levels in AML regardless of mutation status revealed that PHF6 protein levels are higher in patients with AML than normal controls, a finding seemingly at odds with its role as a tumor suppressor (59).